Fixing Sleep Disruptions After Brain Injury: The Thalamocortical Loop
This week BRIGHT has expanded it’s global search from articles focused strictly on Cerebral Palsy to a much wider search of all articles focused on Brain Injury, Stroke, CP, and rehabilitation. This greatly expands the filter from 30 per week to about 200 studies.
Two studies highlight an important new “Additive” theme for BRIGHT: “Sleep Protection” is critically important after a Brain Injury.
Executive Summary: Horizon Filter Evaluation Week 29, July 13th, 2026
A review of global literature published the week of June 29, 2026, yields a new important additive finding to the NeuroLoop Protocol, the importance of Sleep Protection in Brain Injury. Two studies—Necula et al. [DOI: 10.64898/2026.06.24.734382] and a systematic review in Developmental Medicine & Child Neurology [PMID: 42418721]—reinforce BRIGHT’s Step ZERO foundation as well as the CLEAR, SYNC, PRIME, and CEMENT modalities. Together, they demonstrate how structural brain injuries disrupt non-rapid eye movement (NREM) sleep and the critical the Thalamocortical neural loop that shields the brain from long-term decay.
Why HIE Brain Injury Disrupts Sleep
To understand why a Hypoxic-Ischemic Encephalopathy (HIE) event or early brain injury disrupts a child’s sleep, we have to look at the brain’s internal rhythm generator: the thalamocortical loop. This loop is a continuous electrical highway connecting the cortex (the thinking, moving surface of the brain) to the thalamus (the brain’s deep sensory routing station).
HIE heavily damages deep gray matter, specifically the basal ganglia and the thalamus. Because the thalamus acts as the pacemaker for sleep spindles and memory consolidation, thalamic injury causes severe sleep and cognitive disruption. The Necula et al. study highlights Semaphorin-3A (Sema3a) as a mechanism that tunes this exact thalamocortical network to keep the remaining circuits functioning stably.
When the brain is healthy, this highway acts like a synchronized orchestra during NREM sleep. It generates two vital electrical rhythms: slow oscillations (deep, slow brain waves that clear out cellular waste) and sleep spindles (rapid bursts of rhythmic energy that act like a ‘save button’ for memory and motor skills).
When an HIE injury occurs, this delicate scaffolding is torn down. The physical pathways connecting the thalamus and the cortex are disrupted. Starved of clean communication, the brain’s deep pacemaker cells begin to fire erratically, leading to hyper-synchronous excitotoxicity—a state where damaged brain cells become overstimulated, burn out, and actually expand the original injury site during the night.
The study by Necula et al. uncovered the brain’s natural, hidden defender against this nighttime chaos: a guidance molecule called Semaphorin 3A (Sema3a). In a healthy brain, Sema3a steps in after an injury to stabilize these chaotic electrical circuits, safeguarding NREM sleep and protecting the brain’s physical architecture.
But in severe, chronic injuries, the brain’s natural supply of Sema3a is exhausted by ongoing neuro-inflammation. Without this protective shield, sleep breaks down completely. As the Developmental Medicine & Child Neurology systematic review confirms, this structural breakdown leaves individuals with Cerebral Palsy experiencing severe, chronic sleep disruptions at a rate drastically higher than typically developing peers.
The System Hack: Driving the Sema3a Effect Without Drugs
While Sema3a itself is far too experimental and risky to inject or manipulate directly, BRIGHT is not waiting for pharma. Instead, we are using a systems biology hack. The same protective, circuit-stabilizing results that Sema3a produces can be replicated by targeting the underlying loops using safe, non-invasive technology and precise metabolic engineering.
We are hijacking the body’s “system” to force the thalamocortical loop back into harmony, turning sleep from a period of vulnerability into an active neurological support mechanism.
Step ZERO: Restoring the Autonomic Foundation
With 25 years of direct experience with Brain Injury, we know that quality Sleep is one of the largest challenges for both the injured and the caregivers. This is the reason that that Sleep Protection is now anchored directly into Step ZERO: The Stability Index.
Before a child can advance into active, intensive daytime physical rehabilitation, they must first have strong baseline sleep quality. If a child’s brain is drowning in nighttime inflammation and erratic electrical firing, daytime training cannot stick. Step Zero acts as a strict physiological gate. The DECODE domain is focused on measurements. Buy using lightweight, commercial, wearable sleep-tracking tools we can measure sleep quality (the depth of NREM slow waves and the density of sleep spindles). Once this Sleep Stability Index baseline is secure, the brain is officially unlocked and ready for targeted circuit restoration.
The Three Pillars of the Nighttime NeuroLoop
Once Step Zero is established, this same Sleep Protection loop scales seamlessly across all 10 steps of the NeuroLoop, mapping directly to BRIGHT’s core therapeutic domains:
1. CLEAR: Shielding the Synaptic Matrix from Inflammation
Before we can calm the brain’s electrical highways, we must clear the path. Inflammation in the gut releases toxic proteins called cytokines (like IL-6 and TNF-α) that travel up to the brain and physically destroy the delicate nets holding our sleep circuits together.
It is a compounding, multi-front war. The initial HIE brain injury physically damages the brainstem centers that control the vagus nerve, muting it from above. At the exact same time, standard commercial G-tube formulas (often packed with corn syrup solids, maltodextrin, soybean, or canola oils) act like a flamethrower to the gut lining, while lack of physical movement causes gut motility to completely stall. Even if eating orally, we often default to fast food which is as bad or worse then commercial G-tube formulas.
So the first step is to tTransition away from synthetic, sugar-and-seed-oil-based formulas and move toward Real-Food Blenderized Enteral Formulas (BEFs). You can use clean commercial whole-food blends (like Real Food Blends or Functional Formularies Liquid Hope/Nourish) or make your own home-blended whole foods.
Next is a simple and safe anti-inflammatory supplement mix, which can be administered orally or deployed directly as a G-Tube Bolus right before bed. By suspending a highly active, non-proprietary matrix of anti-inflammatory botanical extracts, fatty acids, and a postbiotic, this blend utilizes a natural lipid-based delivery mechanism. The “home brew” formulation works to reinforce gut barrier integrity, downregulate systemic inflammation, and shield the brain’s physical matrix from the destructive cytokine storms that impair NREM sleep. Feel free to contact us directly if you want to discuss real food g-tube and anti-inflammatory supplement mixes.
2. PRIME: The Brainstem U-Turn
With the physical gut / brain axis addressed via diet and supplements, BRIGHT next will use Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) to coax the nervous system out of an anxious, hyper-alert “fight-or-flight” state and drop it into “rest-and-digest” recovery.
By applying gentle, slow-frequency electrical pulses to the sensory skin of the left ear’s cymba concha over a 15-20 minute window right before sleep, we send a sensory (afferent) input signal straight up into the brainstem. The brainstem instantly executes a neurological U-turn, sending a massive parasympathetic wave down the main vagal nerve trunk. This calms the heart, restarts natural gut motility, and acts as a master circuit breaker to lower the baseline defense tone of the entire nervous system ahead of the sleep window. This is in contrast to the exact same use of (taVNS) during the daily rehab sessions were we use the vagus nerve as an “attention stamp” (Neuroplasticity Gating). We fire a brief 1-2 second burst right alongside a movement. We tell the nucleus basalis and locus coeruleus to dump acetylcholine and norepinephrine into the cortex. This acts like a highlighter pen, saying: “Pay attention to the motor loop that just fired.”
3. CEMENT: Locking in the Scaffolding
Finally, once the brain is cleared of inflammation and the body is deeply relaxed, BRIGHT is exploring Auditory Closed-Loop Stimulation (ACLS). As the child sleeps, software listens to their live brain waves via a simple mesh EEG. The moment it detects the start of a native NREM slow wave, it fires a soft, sub-audible pulse of pink noise perfectly timed to the wave’s ascending phase.
Auditory Closed-Loop Stimulation (ACLS) is a practical, safe intervention for children (and adults), utilizing comfortable, dry-sensor mesh bands and flat, under-pillow speakers for stimulation. Pink noise, a calming, rain-like sound, is applied to increase slow-wave sleep without awakening, and studies indicate that targeted stimulation can suppress interictal spikes by up to 75% without triggering seizures. Further studies indicate that this method stabilizes brain activity, preventing the hypersynchronous firing associated with epilepsy.
This calming sound acts as an external pacemaker for the brain. It mimics the natural stabilizing effect of Sema3a, amplifying the amplitude of deep delta waves and packing sleep spindles tightly together. This is where the magic happens: the new motor pathways trained during the day are officially transferred from temporary cortical storage and permanently cemented into stable, lasting neural architecture.
Looking Ahead
Sleep is not passive downtime; it is the arena where neuroplasticity lives or dies. This week’s framework serves as our foundational baseline. In the coming weeks, BRIGHT will dive much deeper into the challenges of Sleep Protection after Brain Injury. However, it is already clear that quality sleep is one of our most powerful tool for neural circuit restoration.
BRIGHT Horizon Filter Week 29
| Status | Core Finding & Target Domain | Source / PMID |
|---|---|---|
| 🟢 Additive Breakthrough | Study 0 (Necula et al.) ➔ Expands NeuroLoop Protocol Architecture: Identifies Sema3a as a critical molecular pathway preserving NREM sleep architecture and shielding memory-critical thalamocortical loops from post-injury decay. | 42427776 |
| 🔴 Strongly Supportive (Clinic-Bound Only) | Study 14 (Alazem et al.) ➔ Supports BRIGHT Mobility Domain: Proves a mobile robotic walker enables precision, moderately intense exercise for GMFCS IV; however, heavy hospital/home robotic footprint limits decentralized independent deployment. | 42423986 |
| 🟡 Supportive | Study 24 (Ryan) ➔ Validates NeuroLoop Metabolic Axis: Explores mitochondrial dysfunction in CP as a primary, systemic pathology rather than a passive byproduct of disuse, supporting targeted bioenergetic therapies. | 42434818 |
| 🟡 Supportive | Study 2 (Syed et al.) ➔ Validates BRIGHT Musculoskeletal Domain: Proves highly non-uniform, localized structural deficits between the gracilis and adductor longus, mandating muscle-specific therapeutic mapping over broad-group interventions. | 42418366 |
| 🟡 Supportive | Study 5 (Sakzewski et al.) ➔ Validates BRIGHT Physical Activity Domain: RCT proves structured, multi-component interventions significantly enhance physically active leisure participation for children with CP. | 42425531 |
| 🔵 Legacy | Study 10 (No authors listed) ➔ Sleep Health Status: Systematic review establishing baseline sleep disturbances and sleep health metrics in adults with cerebral palsy, validating the need for Sleep Protection. | 42418721 |
| 🔵 Legacy | Study 1 (No authors listed) ➔ Musculoskeletal Baseline: Systematic review defining global musculoskeletal health trajectories and secondary degradation patterns among adults with CP. | 42418708 |
| 🔵 Legacy | Study 3 (Wang et al.) ➔ Muscle Morphology: Tracks muscle morphology and intramuscular fat accumulation after standard BoNT-A injections in children with CP. | 42434835 |
| 🔵 Legacy | Study 4 (Lauruschkus) ➔ Community Safety: Investigates frameworks for making community physical activity safer and more sustainable for adults with high support needs. | 42434832 |
| 🔵 Legacy | Study 6 (Mantovani et al.) ➔ Spasticity Surgery: Bibliometric and systematic analysis of global research trends in the surgical management of spasticity. | 42424247 |
| 🔵 Legacy | Study 7 (Byun et al.) ➔ Stepwise Spasticity Management: Case report outlining sequential deployment of SDR, ITB therapy, and DBS in severe pediatric CP. | 42420630 |
| 🔵 Legacy | Study 8 (No authors listed) ➔ Community Safety Strategies: Qualitative case series identifying safety strategies utilized during everyday community physical activity by high-support adults. | 42418730 |
| 🔵 Legacy | Study 9 (Akaltun et al.) ➔ Swallowing Muscle Ultrasonography: Cross-sectional analysis using ultrasonography to evaluate swallowing muscle structure in children with CP and dysphagia. | 42436949 |
| 🔵 Legacy | Study 11 (Landau et al.) ➔ Baclofen Pump Complications: Clinical case report tracking atypical baclofen pump catheter dislodgement in spastic CP. | 42405493 |
| 🔵 Legacy | Study 12 (Ahammad et al.) ➔ Perinatal Risk Modeling: Machine learning driven modeling of synergistic perinatal risk profiles to predict early-onset pediatric CP. | 42436466 |
| 🔵 Legacy | Study 13 (Almomani et al.) ➔ LLM Accuracy in Caregiving: Observational study assessing the accuracy of ChatGPT responses to caregiver questions in pediatric neurology. | 42436249 |
| 🔵 Legacy | Study 15 (Karlsson et al.) ➔ Dysarthria Dataset Protocol: Protocol for developing audio/visual datasets to enable personalized, real-time communication tools for dysarthria. | 42418715 |
| 🔵 Legacy | Study 16 (Katangwe-Chirwa & Jahan) ➔ CP Registers: Evaluates clinical lessons and visibility gained from a decade of CP registries in low- and middle-income countries. | 42435438 |
| 🔵 Legacy | Study 17 (Borges et al.) ➔ Hip Assessment Technology: Examines the measurement properties of the HipScreen App for radiological hip migration assessment in Brazilian children. | 42418998 |
| 🔵 Legacy | Study 18 (No authors listed) ➔ Activity Participation Profiles: Cross-sectional multicenter study evaluating activity and participation levels of children and adolescents with CP in Brazil. | 42418717 |
| 🔵 Legacy | Study 19 (No authors listed) ➔ ICF Framework Epidemiology: Evaluates the epidemiology of CP in Brazil mapped through the lens of the International Classification of Functioning, Disability and Health. | 42418711 |
| 🔵 Legacy | Study 20 (Dalpatadu et al.) ➔ Quality of Life Profiles: Links functional and social factors to domain-specific quality of life profiles in low- and middle-income country cohorts. | 42415135 |
| 🔵 Legacy | Study 21 (Costagli et al.) ➔ Remote General Movements Assessment: Feasibility study of using the Baby Moves app for remote tracking in an Italian infant population. | 42413968 |
| 🔵 Legacy | Study 22 (Bakuwa et al.) ➔ Caregiver Training Feasibility: Feasibility RCT comparing caregiver-led vs. therapist-led training programs for caregivers in rural Malawi. | 42410399 |
| 🔵 Legacy | Study 23 (Romeros et al.) ➔ Sedentary Behavior Patterns: Quantifies physical activity and sedentary behavior patterns of Brazilian children and adolescents with CP. | 42407436 |
| 🔵 Legacy | Study 25 (Herheim et al.) ➔ Pain Management Experiences: Qualitative study mapping the experiences of physiotherapists treating children and adolescents with CP experiencing chronic pain. | 42429178 |
| 🔵 Legacy | Study 26 (No authors listed) ➔ WHO Healthy Ageing Model: Systematic review applying the World Health Organization Healthy Ageing model to intrinsic capacity measures in adults with CP. | 42418756 |
| 🔵 Legacy | Study 27 (Branagan et al.) ➔ Neonatal Encephalopathy Consensus: International real-time Delphi consensus process defining neonatal encephalopathy parameters. | 42409040 |
| 🔵 Legacy | Study 28 (No authors listed) ➔ Socio-Emotional Trajectories: Longitudinal cohort study mapping socio-emotional development trajectories in infants at high risk of CP. | 42418706 |
| 🔵 Legacy | Study 29 (Hernández-Pérez et al.) ➔ Preterm Neurological Outcomes: Clinical and cranial ultrasound findings tracking neurological outcomes in extremely preterm infants with periventricular hemorrhagic infarction. | 42410045 |
Technical Glossary:
Here is the technical glossary for the Week 29 Sleep Protection framework. These definitions translate the complex neurological and systems-biology terms used in the BRIGHT protocol into clean, actionable concepts.
Neurological & Circuit Architecture Terms
- Thalamocortical Loop
The primary electrical highway of sleep. It is a continuous feedback loop connecting the thalamus (the deep sensory routing station) and the cortex (the brain’s outer surface). This loop must be perfectly synchronized to generate the brain waves required for deep sleep and motor healing. [1] - NREM (Non-Rapid Eye Movement) Sleep
The quiet, deep stages of sleep distinct from dreaming (REM) sleep. NREM is divided into light and deep stages. For BRIGHT, deep NREM is the critical “rehabilitation window” where the brain repairs tissues, clears metabolic waste, and consolidates physical skills. [2, 3, 4, 5, 6] - Slow Oscillations (Slow Waves / Delta Waves)
Deep, highly synchronized brain waves (ranging from 0.5 to 4.0 Hz) that occur during deep NREM sleep. They act like a slow pump, driving cerebral spinal fluid to flush out cellular waste and calming over-excited neurons. [7, 8, 9, 10, 11] - Sleep Spindles
Rapid, rhythmic bursts of brain activity (11 to 16 Hz) lasting 1–2 seconds during NREM sleep. They serve as the brain’s internal “save button,” physically transferring new motor maps and information from temporary cortical storage into long-term neural memory. [12, 13, 14, 15, 16] - Hyper-Synchronous Excitotoxicity
A pathological state where damaged or unguided brain cells fire uncontrollably out of sync. Instead of resting during sleep, the cells overstimulate themselves to the point of exhaustion, which can cause secondary damage and expand an existing brain lesion. - Semaphorin 3A (Sema3a)
An innate neural guidance molecule. Following a brain injury, it acts as a local circuit stabilizer, guiding synaptic wiring and protecting NREM sleep architecture. In chronic injury or high inflammation, the brain’s natural supply of Sema3a can become exhausted. - Perineuronal Nets (PNNs)
Specialized structures made of proteins and sugars that wrap around vital neurons like a physical lattice or “hairnet.” They lock synapses into place, maintaining circuit stability and housing protection molecules like Sema3a. Systemic inflammation degrades these nets.
Neuromodulation & Technology Terms
- Auditory Closed-Loop Stimulation (ACLS)
A non-invasive technology that listens to live brain waves via an EEG patch and delivers precisely timed, ultra-soft pulses of sound (pink noise) locked exactly to the rising phase of a native NREM slow wave. This acts as an external pacemaker to amplify deep sleep waves. - Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
A safe, non-invasive method of stimulating the vagus nerve via an electrical clip applied to the outer ear (specifically the left cymba concha or tragus). - Vagovagal Reflex Loop (The Brainstem U-Turn)
The neurological reflex circuit where a sensory (afferent) signal traveling up from the ear tells the brainstem’s processing center to instantly fire a restorative, parasympathetic (efferent) signal down the main vagus nerve trunk to calm the heart and restore gut function. - Neuroplastic Gating (Motor Gating)
The practice of pairing brief, high-frequency vagus nerve stimulation bursts (Profile A: ~25 Hz) directly with a physical movement. This floods the cortex with attention chemicals, acting like a highlighter pen to “stamp” and lock in that specific motor circuit.
Systems Biology & Metabolic Terms
- Hypoxic-Ischemic Encephalopathy (HIE)
A type of brain injury caused by a lack of oxygen (hypoxia) and a lack of blood flow (ischemia) to the brain, frequently occurring around the time of birth, which can disrupt foundational thalamocortical pathways. - Cholinergic Anti-Inflammatory Pathway
A major neural brake system. When the vagus nerve fires, it releases a neurotransmitter called acetylcholine (ACh). This chemical binds to inflammatory cells in the gut and spleen, instantly shutting down the production of toxic, inflammatory proteins. - Cytokines (IL-6 and TNF-α)
Pro-inflammatory signaling proteins (specifically Interleukin-6 and Tumor Necrosis Factor-alpha). When the gut is inflamed, these cytokines flood the bloodstream, cross the blood-brain barrier, and degrade the brain’s protective perineuronal nets. - NF-κB Pathway
The primary genetic master-switch for inflammation inside cells. When activated by stress or injury, it enters the cell nucleus and orders the immediate production of inflammatory cytokines.
[2] https://www.studysmarter.co.uk
[3] https://somnussleepcenter.com
[4] https://www.sleepclinicpretoria.co.za
[5] https://veresiesclinic.com
[6] https://www.sciencedirect.com
[7] https://www.sleepfoundation.org
[8] https://pmc.ncbi.nlm.nih.gov
[9] https://pmc.ncbi.nlm.nih.gov
[10] https://www.sciencefocus.com
[11] https://www.sciencedirect.com
[12] https://www.thesleepreset.com
[14] https://pmc.ncbi.nlm.nih.gov
[15] https://thebettersleepclinic.com
Detailed Citation List
| Citation | PMID |
| 1.Musculoskeletal health among adults with cerebral palsy: A systematic review No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418708 | 42418708 |
| 2.Non-uniform hip adductor muscle deficits in children with cerebral palsy: A comparison between the gracilis and adductor longus Faizan Syed, Latif Omerkhil, Jason J Howard, Christopher Tiessen, Sunnie Vuong, Ruth-Anne Seerattan, Gavin K Thomas, Sach Dabgotra, Isaac Obrigewitsch, Shuyue Liu, Timothy R Leonard, Venus Joumaa, Walter Herzog Am J Physiol Cell Physiol. 2026 Jul 8. Online ahead of print. PMID: 42418366 | 42418366 |
| 3.Muscle morphology and intramuscular fat after treatment-as-usual including botulinum neurotoxin A injections in children with cerebral palsy Zhongzheng Wang, Antea Destro, Alexandra Åhblom, Sven Petersson, Ferdinand Von Walden, Eva Pontén, Cecilia Lidbeck, Ruoli Wang Dev Med Child Neurol. 2026 Jul 11. Online ahead of print. PMID: 42434835 | 42434835 |
| 4.Making community physical activity safer and more sustainable for adults with cerebral palsy and high support needs Katarina Lauruschkus Dev Med Child Neurol. 2026 Jul 11. Online ahead of print. PMID: 42434832 | 42434832 |
| 5.Enhancing Physically Active Leisure Participation for Children With Cerebral Palsy: A Randomized Controlled Trial Leanne Sakzewski, Sarah Reedman, Catherine Elliott, Iona Novak, Stewart G Trost, Annette Majnemer, Keiko Shikako, Robert Ware, Lynda McNamara, Sian Williams, Denise Brookes, Roslyn N Boyd Pediatrics. 2026 Jul 10:e2025075162. Online ahead of print. PMID: 42425531 | 42425531 |
| 6.Global Research Trends in the Surgical Management of Spasticity: A Systematic Review and Bibliometric Analysis Giorgio Mantovani, Corentin Dauleac, Michele Alessandro Cavallo, Patrick Mertens Stereotact Funct Neurosurg. 2026 Jul 9:1-20. Online ahead of print. PMID: 42424247 | 42424247 |
| 7.Stepwise surgical management of spasticity and dystonia in severe pediatric cerebral palsy: a case report involving selective dorsal rhizotomy, intrathecal baclofen therapy, and deep brain stimulation Jong Won Byun, Jae Meen Lee, Yong Beom Shin, Jin A Yoon, Soo-Yeon Kim Childs Nerv Syst. 2026 Jul 9;42(1):291. PMID: 42420630 | 42420630 |
| 8.Safety strategies used for everyday community physical activity by adults with cerebral palsy and high support needs: A qualitative case series No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418730 | 42418730 |
| 9.Swallowing Muscle Ultrasonography in Children With Cerebral Palsy and Dysphagia: A Cross-Sectional Study Mazlum Serdar Akaltun, Bülent Alyanak, Ebru Umay Laryngoscope Investig Otolaryngol. 2026 Jul 10;11(4):e70501. eCollection 2026 Aug. PMID: 42436949 | 42436949 |
| 10.Sleep health of adults with cerebral palsy: A systematic review No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418721 | 42418721 |
| 11.Atypical baclofen pump catheter dislodgement in spastic cerebral palsy – A case report Alex Landau, Kevin Batti, Tejas Shah, Andrew Kobets, Yuxi Chen J Pediatr Rehabil Med. 2026 Jul 6:18758894261454112. Online ahead of print. PMID: 42405493 | 42405493 |
| 12.Machine learning driven modeling of synergistic perinatal risk profiles in early onset pediatric cerebral palsy Foysal Ahammad, Munira Aden, Ayesha Banu, Muhammad Marwan, Sadam Hussain, Safa Salim, Adnan Mohammed, Tanvir Alam, Lisa Thornton, Farhan Mohammad BMC Med Inform Decis Mak. 2026 Jul 11. Online ahead of print. PMID: 42436466 | 42436466 |
| 13.Assessing the accuracy of ChatGPT responses to caregiver questions in pediatric neurology: an observational study Miral A Almomani, Basima A Almomani, Hashim Al-Qudah, Rawan Abed Alrahman, Seleina O El-Bawaneh, Sondos Hawari, Ahmad A Alqudah Sci Rep. 2026 Jul 11. Online ahead of print. PMID: 42436249 | 42436249 |
| 14.Mobile robotic walker enables precision moderately intense exercise and environmental exploration in a child with cerebral palsy GMFCS IV: assessment of use, user experience and quantitative impact in a home and hospital based setting Hana Alazem, Anya H Friesen, Taylor Dennison, Adina Nizam, Michelle L Larin, Patricia E Longmuir, Hugh J McMillan, Alicia Hilderley, Anna M McCormick Sci Rep. 2026 Jul 11. Online ahead of print. PMID: 42423986 | 42423986 |
| 15.My Voice Library: Protocol for Developing Audio and Visual Datasets to Enable Personalized Real-Time Communication for People With Dysarthria Petra Karlsson, Andrea Bandini, Michelle McInerney, Hayley Smithers-Sheedy, Annemarie Murphy, Maria Dalmon, Alistair McEwan, Silvia Orlandi JMIR Res Protoc. 2026 Jul 8;15:e97614. PMID: 42418715 | 42418715 |
| 16.Making invisible children visible: Lessons from a decade of cerebral palsy registers in low- and middle-income countries Thembi Katangwe-Chirwa, Israt Jahan Dev Med Child Neurol. 2026 Jul 11. Online ahead of print. PMID: 42435438 | 42435438 |
| 17.Measurement properties of the HipScreen App for radiological hip migration assessment in Brazilian children with cerebral palsy Giovana R Borges, Patricia Eduarda C M R Jaleca, Nadine O Cabral, Júlia S Castilho, Yasmín E G Herrera, Vedant A Kulkarni, Paula S C Chagas, Aline M Toledo, Patricia M Grangeiro, Kennea M A Ayupe Braz J Phys Ther. 2026 Jul 8;30(5):101604. Online ahead of print. PMID: 42418998 | 42418998 |
| 18.Activity and participation of children and adolescents with cerebral palsy: A cross-sectional multicenter study in Brazil No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418717 | 42418717 |
| 19.Epidemiology of cerebral palsy in Brazil through the lens of the International Classification of Functioning, Disability and Health framework No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418711 | 42418711 |
| 20.Association of functional and social factors with domain-specific quality of life profiles in children with cerebral palsy: findings from a low- and middle-income country S A C Dalpatadu, T C M G D P Cooray, Chryshanth Dalpatadu BMC Res Notes. 2026 Jul 7. Online ahead of print. PMID: 42415135 | 42415135 |
| 21.Feasibility of the Baby Moves app for remote General Movements Assessment: a prospective observational cohort study in an Italian infant population Ginevra Costagli, Lucia Rocchitelli, Olena Chorna, Sabrina Del Secco, Giulia Corsi, Colleen Peyton, Alicia J Spittle, Amanda Ka-Ling Kwong, Andrea Guzzetta BMJ Paediatr Open. 2026 Jul 6;10(1):e004361. PMID: 42413968 | 42413968 |
| 22.Caregiver-led versus therapist-led training programme for caregivers of children with cerebral palsy in rural Malawi: a feasibility randomised controlled trial Takondwa Connis Bakuwa, Gillian Saloojee, Wiedaad Slemming BMC Pediatr. 2026 Jul 7. Online ahead of print. PMID: 42410399 | 42410399 |
| 23.Physical Activity and Sedentary Behavior Patterns of Brazilian Children and Adolescents With Cerebral Palsy Angélica Cristina Sousa Fonseca Romeros, Deisiane Oliveira Souto, Elton Duarte Dantas Magalhães, Maria Eduarda de Araújo Almeida Muniz, Letícia Vicente Menigatti, Ana Cristina Resende Camargos, Kennea Martins Almeida Ayupe, Paula Silva de Carvalho Chagas, Hércules Ribeiro Leite Pediatr Phys Ther. 2026 Jul 7. Online ahead of print. PMID: 42407436 | 42407436 |
| 24.Mitochondrial dysfunction in cerebral palsy: More than a consequence of disuse? Terence E Ryan Dev Med Child Neurol. 2026 Jul 11. Online ahead of print. PMID: 42434818 | 42434818 |
| 25.”My aim is to contribute to a meaningful life.” Experiences of physiotherapists treating children and adolescents with cerebral palsy experiencing pain-a qualitative study Bodil Herheim, Reidun B Jahnsen, Agneta Anderzén-Carlsson Disabil Rehabil. 2026 Jul 10:1-13. Online ahead of print. PMID: 42429178 | 42429178 |
| 26.World Health Organization Healthy Ageing model applied to adults with cerebral palsy: A systematic review of reported intrinsic capacity measures No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418756 | 42418756 |
| 27.Defining neonatal encephalopathy: an international real-time Delphi consensus process Aoife Branagan, Tim Hurley, Dearbhla Byrne, Fiona Quirke, Declan Devane, Petek E Taneri, Nadia Badawi, Cynthia F Bearer, Frank H Bloomfield, Sonia L Bonifacio, Geraldine Boylan, Suzann K Campbell, Lina Chalak, Mary D’Alton, Linda S de Vries, Mohamed El-Dib, Donna M Ferriero, Chris Gale, Pierre Gressens, Toto Gronlund, Alistair J Gunn, Sarah Kay, Deirdre M Murray, Karin B Nelson, Betsy Pilon, Nicola J Robertson, Karen Walker, Courtney J Wusthoff, Eleanor J Molloy; Steering Group for DEFiNE (Definition of Neonatal Encephalopathy) Lancet Child Adolesc Health. 2026 Jul 6:S2352-4642(26)00101-X. Online ahead of print. PMID: 42409040 | 42409040 |
| 28.Socio-emotional development trajectories in infants at high risk of cerebral palsy: A longitudinal cohort study No authors listed Dev Med Child Neurol. 2026 Jul 8. Online ahead of print. PMID: 42418706 | 42418706 |
| 29.Neurological outcomes in extremely preterm infants with periventricular hemorrhagic infarction: clinical and cranial ultrasound findings Raquel Hernández-Pérez, María Arriaga-Redondo, Alejandra Aguado Del Hoyo, Jessica Merchán-Naranjo, Laura Pina-Camacho, Manuel Sánchez-Luna, Dorotea Blanco-Bravo Eur J Pediatr. 2026 Jul 6;185(7):553. PMID: 42410045 | 42410045 |
Creator Credentials
Author: Matt Palaszynski
- Founder, BRIGHT Foundation: Leading a global initiative to “close the loop” on Cerebral Palsy recovery through data-driven research.
- 25+ Years Lived Experience: Navigating life with a daughter with CP provides a primary, first-person understanding of the physiological and clinical gaps in current care models.
- GE Alumnus & Business Leader: Leveraging decades of experience in operational excellence, complex systems, and strategic leadership to apply rigorous meta-study frameworks to neurological research.
- Methodology: Combines personal advocacy with professional systems-thinking to synthesize NCBI PubMed data into the actionable NeuroLoop Protocol.
Conflict of Interest Statement
The BRIGHT Foundation and its founder, Matt Palaszynski, maintain no commercial or business interests in the medical technologies, pharmaceutical products, or clinical services discussed on this page.
- Non-Profit Mission: Our objective is purely research-driven, aimed at identifying the most effective paths to a functional cure.
- Independence: No funding is received from manufacturers of the devices or therapies reviewed in our weekly meta-studies.
- Transparency: All citations are linked directly to PubMed (PMIDs) to ensure users can verify the raw data independently.
